Cyanotech Current Ratio 2006-2019 | CYAN

Cyanotech current ratio from 2006 to 2019. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Cyanotech Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2019-12-31 $0.02B $0.01B 2.10
2019-09-30 $0.01B $0.01B 2.05
2019-06-30 $0.02B $0.01B 1.85
2019-03-31 $0.02B $0.01B 1.54
2018-12-31 $0.01B $0.01B 1.77
2018-09-30 $0.01B $0.01B 1.80
2018-06-30 $0.01B $0.01B 1.99
2018-03-31 $0.01B $0.01B 2.39
2017-12-31 $0.02B $0.01B 2.44
2017-09-30 $0.01B $0.01B 2.36
2017-06-30 $0.01B $0.01B 2.25
2017-03-31 $0.01B $0.01B 2.03
2016-12-31 $0.01B $0.01B 2.02
2016-09-30 $0.01B $0.01B 1.93
2016-06-30 $0.01B $0.01B 1.87
2016-03-31 $0.01B $0.01B 2.07
2015-12-31 $0.01B $0.01B 2.25
2015-09-30 $0.01B $0.01B 2.28
2015-06-30 $0.01B $0.01B 2.34
2015-03-31 $0.01B $0.00B 2.73
2014-12-31 $0.01B $0.01B 2.63
2014-09-30 $0.01B $0.01B 2.36
2014-06-30 $0.01B $0.00B 2.74
2014-03-31 $0.01B $0.00B 3.03
2013-12-31 $0.01B $0.00B 3.62
2013-09-30 $0.01B $0.00B 3.97
2013-06-30 $0.01B $0.00B 3.81
2013-03-31 $0.01B $0.00B 4.23
2012-12-31 $0.01B $0.00B 4.12
2012-09-30 $0.01B $0.00B 3.44
2012-06-30 $0.01B $0.00B 4.13
2012-03-31 $0.01B $0.00B 3.40
2011-12-31 $0.01B $0.00B 3.91
2011-09-30 $0.01B $0.00B 3.93
2011-06-30 $0.01B $0.00B 4.15
2011-03-31 $0.01B $0.00B 3.86
2010-12-31 $0.01B $0.00B 4.02
2010-09-30 $0.01B $0.00B 4.44
2010-06-30 $0.01B $0.00B 3.46
2010-03-31 $0.01B $0.00B 3.18
2009-12-31 $0.01B $0.00B 3.52
2009-09-30 $0.01B $0.00B 3.33
2009-06-30 $0.01B $0.00B 2.67
2009-03-31 $0.01B $0.00B 2.85
2008-12-31 $0.01B $0.00B 2.73
2008-09-30 $0.01B $0.00B 2.43
2008-06-30 $0.01B $0.00B 2.55
2008-03-31 $0.01B $0.00B 2.72
2007-12-31 $0.00B $0.00B 1.92
2007-09-30 $0.00B $0.00B 2.51
2007-06-30 $0.00B $0.00B 3.54
2007-03-31 $0.01B $0.00B 3.39
2006-12-31 $0.01B $0.00B 3.68
2006-09-30 $0.01B $0.00B 5.29
2006-06-30 $0.01B $0.00B 5.23
2006-03-31 $0.01B $0.00B 5.45
2005-12-31 $0.01B $0.00B 4.80
2005-09-30 $0.01B $0.00B 5.11
2005-06-30 $0.01B $0.00B 4.77
2005-03-31 $0.01B $0.00B 3.97
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.013B $0.030B
CYANOTECH CORP. develops and commercializes natural products from microalgae. Co. is currently producing microalgae products for the nutritional supplement and immunological diagnostics markets and is also developing microalgae-based products for the aquaculture feed/pigments, biopesticide and food coloring markets. Microalgae are a diverse group of over 30,000 species of microscopic plants which have a wide range of physiological and biochemical characteristics and naturally contain high levels of nutrients.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $59.894B 34.65
Takeda Pharmaceutical (TAK) Japan $49.971B 8.76
Astellas Pharma (ALPMY) Japan $28.823B 14.40
Eisai (ESALY) Japan $20.591B 38.36
UCB SA (UCBJF) Belgium $15.687B 0.00
Grifols, S.A (GRFS) Spain $13.751B 17.09
Merck (MKGAF) Germany $12.892B 16.91
Ono Pharmaceutical (OPHLF) Japan $9.254B 19.78
Neurocrine Biosciences (NBIX) United States $8.704B 241.82
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $7.874B 0.00
Catalent (CTLT) United States $7.719B 31.76
Ionis Pharmaceuticals (IONS) United States $6.971B 21.13
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.906B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $5.906B 7.20
Orion OYJ (ORINY) Finland $5.269B 23.61
IPSEN SA ADR (IPSEY) France $4.719B 0.00
STADA ARZNEIMI (STDAF) Germany $4.685B 0.00
Forty Seven (FTSV) United States $4.599B 0.00
United Therapeutics (UTHR) United States $4.172B 0.00
Evotec AG (EVTCY) Germany $3.769B 60.79
Hypermarcas (HYPMY) Brazil $3.681B 11.20
Nektar Therapeutics (NKTR) United States $3.123B 0.00
FibroGen (FGEN) United States $3.003B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.988B 55.45
PTC Therapeutics (PTCT) United States $2.680B 0.00
ChemoCentryx (CCXI) United States $2.626B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.366B 9.57
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.628B 0.00
Xencor (XNCR) United States $1.607B 65.63
Ironwood Pharmaceuticals (IRWD) United States $1.525B 18.54
Sage Therapeutics (SAGE) United States $1.507B 0.00
USANA Health Sciences (USNA) United States $1.495B 15.70
Theravance Biopharma (TBPH) Cayman Islands $1.421B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.372B 37.51
Corcept Therapeutics (CORT) United States $1.261B 14.10
Heron Therapeutics (HRTX) United States $1.225B 0.00
Karyopharm Therapeutics (KPTI) United States $1.218B 0.00
Zogenix (ZGNX) United States $1.081B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.015B 31.43
Esperion Therapeutics (ESPR) United States $0.909B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $0.871B 12.13
Akebia Therapeutics (AKBA) United States $0.870B 0.00
CLINIGEN GP (CLIGF) United Kingdom $0.802B 0.00
Endo (ENDP) Ireland $0.730B 1.35
Tilray (TLRY) Canada $0.663B 0.00
Molecular Templates (MTEM) United States $0.637B 0.00
Translate Bio (TBIO) United States $0.617B 0.00
Collegium Pharmaceutical (COLL) United States $0.604B 0.00
ImmunoGen (IMGN) United States $0.591B 0.00
Aerie Pharmaceuticals (AERI) United States $0.590B 0.00
Radius Health (RDUS) United States $0.565B 0.00
Portola Pharmaceuticals (PTLA) United States $0.517B 0.00
Siga Technologies (SIGA) United States $0.418B 0.00
Indivior (INVVY) United States $0.401B 2.38
BioSpecifics Technologies Corp (BSTC) United States $0.401B 16.45
Innate Pharma SA (IPHYF) France $0.385B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.385B 12.83
Calithera Biosciences (CALA) United States $0.371B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.370B 0.00
Ardelyx (ARDX) United States $0.353B 0.00
Organogenesis Holdings (ORGO) United States $0.327B 0.00
Trillium Therapeutics (TRIL) Canada $0.324B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.320B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.310B 0.00
DURECT (DRRX) United States $0.300B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.299B 0.00
Flexion Therapeutics (FLXN) United States $0.295B 0.00
Lannett Co Inc (LCI) United States $0.289B 4.65
Harpoon Therapeutics (HARP) United States $0.287B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.276B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.272B 0.00
Ocular Therapeutix (OCUL) United States $0.264B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.262B 0.00
TherapeuticsMD (TXMD) United States $0.243B 0.00
Concert Pharmaceuticals (CNCE) United States $0.242B 0.00
Rafael Holdings (RFL) United States $0.209B 0.00
OptiNose (OPTN) United States $0.182B 0.00
CASI Pharmaceuticals (CASI) United States $0.182B 0.00
Recro Pharma (REPH) United States $0.178B 0.00
PROFOUND MEDICL (PROF) Canada $0.172B 0.00
MEI Pharma (MEIP) United States $0.160B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.154B 0.00
Jounce Therapeutics (JNCE) United States $0.154B 2.77
Nature's Sunshine Products (NATR) United States $0.148B 18.58
KalVista Pharmaceuticals (KALV) United States $0.138B 0.00
Taiwan Liposome (TLC) Taiwan $0.137B 0.00
Redhill Biopharma (RDHL) Israel $0.134B 0.00
VAXART, INC (VXRT) United States $0.119B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.107B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.103B 0.00
CannTrust Holdings (CTST) Canada $0.090B 0.00
SCYNEXIS (SCYX) United States $0.084B 0.00
Champions Oncology (CSBR) United States $0.083B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.083B 0.00
IMV INC (IMV) Canada $0.081B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.079B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.076B 0.00
Hemispherx BioPharma (AIM) United States $0.072B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.072B 0.00
Biomerica (BMRA) United States $0.072B 0.00
CTI BioPharma (CTIC) United States $0.070B 0.00
Aquestive Therapeutics (AQST) United States $0.069B 0.00
Xeris Pharmaceuticals (XERS) United States $0.064B 0.00
CV Sciences (CVSI) United States $0.064B 0.00
Otonomy (OTIC) United States $0.060B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.055B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.055B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.054B 16.95
Nivalis Therapeutics (ALPN) United States $0.052B 0.00
PharmAthene (ALT) United States $0.051B 0.00
Infinity Pharmaceuticals (INFI) United States $0.051B 0.00
Onconova Therapeutics (ONTX) United States $0.049B 0.00
Aclaris Therapeutics (ACRS) United States $0.047B 0.00
Natural Alternatives (NAII) United States $0.045B 20.34
Sundial Growers (SNDL) Canada $0.043B 0.00
GTx (ONCT) United States $0.043B 0.00
MediWound (MDWD) Israel $0.042B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.039B 131.71
Neos Therapeutics (NEOS) United States $0.038B 0.00
Forward Pharma (FWP) Denmark $0.038B 0.00
Iterum Therapeutics (ITRM) Ireland $0.037B 0.00
PolarityTE (PTE) United States $0.033B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.033B 0.00
IsoRay (ISR) United States $0.031B 0.00
AgeX Therapeutics (AGE) United States $0.031B 0.00
Heat Biologics (HTBX) United States $0.028B 0.00
ElectroCore (ECOR) United States $0.026B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.025B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.025B 0.00
Cardiome Pharma (CORV) Canada $0.024B 0.00
Jaguar Animal Health (JAGX) United States $0.024B 0.00
Mannatechorporated (MTEX) United States $0.023B 7.13
Eyegate Pharmaceuticals (EYEG) United States $0.023B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.022B 0.00
ProPhase Labs (PRPH) United States $0.022B 0.00
Lipocine (LPCN) United States $0.022B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.021B 0.00
India Globalization Capital (IGC) United States $0.018B 0.00
Bio-Path Holdings (BPTH) United States $0.017B 0.00
Novan (NOVN) United States $0.016B 0.00
Can-Fite Biopharma (CANF) Israel $0.013B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.012B 0.00
Shineco (TYHT) China $0.012B 0.00
KemPharm (KMPH) United States $0.011B 0.00
China SXT Pharmaceuticals (SXTC) China $0.011B 0.00
Vical (BBI) United States $0.010B 0.00
Regulus Therapeutics (RGLS) United States $0.010B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.010B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.008B 0.00
Midatech Pharma (MTP) United Kingdom $0.007B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.006B 0.00
HANCOCK JAFFE (HJLI) United States $0.005B 0.00
RXi Pharmaceuticals (PHIO) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Flex Pharma (SLRX) United States $0.003B 0.00